When did NUVECTIS PHARMA INC (NVCT) report earnings last quarter?
NUVECTIS PHARMA INC (NVCT) last reported earnings on 2/11/2026.
NUVECTIS PHARMA INC (NVCT) Earnings History & Surprises
NASDAQ:NVCT • US67080T1088
Current stock price
8.54 USD
-0.02 (-0.23%)
Last:
NVCT Earnings overview
Past quarterly earnings results for NUVECTIS PHARMA INC (NVCT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 12, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.32
- Revenue Estimate
Last Reported
Most Recent- Release Date
- Feb 11, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.31
- EPS Surprise
- -2.16%
- Revenue Surprise
- %
Beat Rate
Last 8 Quarters 19%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.31 | -0.30 | -2.16% | 13.89% | - | - | ||
| Q3 2025 | -0.33 | -0.25 | -30.72% | -37.50% | - | - | ||
| Q2 2025 | -0.30 | -0.26 | -15.34% | -15.38% | - | - | ||
| Q1 2025 | -0.27 | -0.26 | -4.21% | -8.00% | - | - | ||
| Q4 2024 | -0.36 | -0.26 | -39.50% | 12.20% | - | - | ||
| Q3 2024 | -0.24 | -0.26 | 6.75% | 35.14% | - | - | ||
| Q2 2024 | -0.26 | -0.27 | 1.96% | 31.58% | - | - | ||
| Q1 2024 | -0.25 | -0.40 | 38.21% | 7.41% | - | - | ||
| Q4 2023 | -0.41 | -0.37 | -10.13% | -4.41% | - | - | ||
| Q3 2023 | -0.37 | -0.35 | -5.96% | 11.90% | - | - | ||
| Q2 2023 | -0.38 | -0.30 | -27.73% | -35.71% | - | - | ||
| Q1 2023 | -0.27 | -0.45 | 40.02% | 15.62% | - | - | ||
| Q4 2022 | -0.39 | - | 18.19% | - | - | |||
| Q3 2022 | -0.42 | -0.28 | -52.51% | - | - | - | ||
| Q2 2022 | -0.28 | -0.24 | -17.65% | - | - | - | ||
| Q1 2022 | -0.32 | -0.23 | -36.40% | - | - | - | ||
| Q4 2021 | -0.48 | -0.87 | 44.64% | - | - | - | ||
| Q2 2021 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
0
Average EPS beat (4)
-13.11%
Max EPS beat (4)
-2.16%
Min EPS beat (4)
-30.72%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, NVCT has not beaten EPS estimates in any release
In the last 4 quarters, NVCT reported -13.1% below the EPS estimates on average.
Related analysis
NUVECTIS PHARMA INC / NVCT Earnings FAQ
Can you provide information on whether NUVECTIS PHARMA INC beat earnings estimates in the last quarter?
NUVECTIS PHARMA INC (NVCT) missed EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does NVCT stock beat earnings estimates?
In the last 4 quarters, NUVECTIS PHARMA INC (NVCT) has beaten EPS estimates in 0 out of 4 releases.